59 companies

Firebrick Pharma

Market Cap: AU$19.1m

Engages in the development and commercializing of novel formulations for the uses of povidone iodine in Australia.

FRE

AU$0.091

7D

-3.2%

1Y

75.0%

Alterity Therapeutics

Market Cap: AU$49.4m

Engages in the research and development of therapeutic drugs to treat Alzheimer’s disease, Huntington disease, Parkinson’s disease, and other neurological disorders in Australia.

ATH

AU$0.009

7D

-10.0%

1Y

100.0%

Little Green Pharma

Market Cap: AU$40.9m

Engages in the cultivation, production, and distribution of medicinal cannabis products in Australia and internationally.

LGP

AU$0.14

7D

3.8%

1Y

3.8%

Clinuvel Pharmaceuticals

Market Cap: AU$584.4m

A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.

CUV

AU$11.70

7D

0.8%

1Y

-14.9%

Vita Life Sciences

Market Cap: AU$108.5m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

VLS

AU$1.95

7D

1.6%

1Y

-18.8%

Immutep

Market Cap: AU$422.1m

A late-stage biotechnology company, engages in developing novel LAG-3 related immunotherapies for cancer and autoimmune diseases in Australia.

IMM

AU$0.29

7D

-1.7%

1Y

-24.7%

Invion

Market Cap: AU$8.9m

A clinical-stage life-sciences company, researches and develops Photosoft technology for the treatment of cancers, atherosclerosis, and infectious diseases in Australia.

IVX

AU$0.12

7D

-8.0%

1Y

-77.0%

LTR Pharma

Market Cap: AU$86.9m

A biopharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia.

LTP

AU$0.48

7D

-20.0%

1Y

57.4%

Algorae Pharmaceuticals

Market Cap: AU$8.4m

A pharmaceutical development company, engages in the research and development of living cells technologies primarily in New Zealand.

1AI

AU$0.005

7D

-16.7%

1Y

-44.4%

Argenica Therapeutics

Market Cap: AU$102.5m

A biotechnology company, engages in the research and development of neuroprotective therapeutic drug in Australia.

AGN

AU$0.80

7D

3.2%

1Y

33.3%

Neuren Pharmaceuticals

Market Cap: AU$1.6b

A biopharmaceutical company, develops drugs for the treatment of neurological disorders.

NEU

AU$12.62

7D

2.6%

1Y

-37.6%

Nyrada

Market Cap: AU$21.0m

A pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.

NYR

AU$0.10

7D

0%

1Y

4.2%

Arovella Therapeutics

Market Cap: AU$89.4m

A biotechnology company, focuses on the development of therapies for the treatment of cancer in Australia and internationally.

ALA

AU$0.084

7D

-16.0%

1Y

-35.4%

Radiopharm Theranostics

Market Cap: AU$65.4m

Engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical needs.

RAD

AU$0.028

7D

-12.5%

1Y

-50.9%

Clarity Pharmaceuticals

Market Cap: AU$784.1m

A clinical stage radiopharmaceutical company, engages in research and development and clinical stage radiopharmaceuticals products in Australia and the United States.

CU6

AU$2.44

7D

-13.2%

1Y

-14.4%

Biotron

Market Cap: AU$2.7m

A biotechnology company, engages in developing and commercializing small molecule products to treat various viral diseases in Australia.

BIT

AU$0.003

7D

0%

1Y

-96.1%

Actinogen Medical

Market Cap: AU$106.5m

A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.

ACW

AU$0.034

7D

0%

1Y

19.3%

Invex Therapeutics

Market Cap: AU$5.4m

A biopharmaceutical company, engages in the research and development of treatments for neurological conditions in Australia.

IXC

AU$0.072

7D

2.9%

1Y

-15.3%

Race Oncology

Market Cap: AU$191.1m

A clinical stage biopharmaceutical company, focuses on addressing the unmet needs of cancer patients for damaging treatments.

RAC

AU$1.10

7D

-8.3%

1Y

-19.7%

EZZ Life Science Holdings

Market Cap: AU$73.8m

Engages in formulation, production, marketing, and sale of the health and wellbeing products in Australia, New Zealand, Mainland China, and internationally.

EZZ

AU$1.57

7D

3.6%

1Y

203.9%

Percheron Therapeutics

Market Cap: AU$12.0m

Engages in the research and development of novel antisense pharmaceuticals in Australia.

PER

AU$0.011

7D

10.0%

1Y

-87.4%

PYC Therapeutics

Market Cap: AU$629.9m

A drug-development company, engages in the discovery and development of novel RNA therapeutics for the treatment of genetic diseases in Australia.

PYC

AU$1.35

7D

16.9%

1Y

66.7%

Orthocell

Market Cap: AU$359.9m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

OCC

AU$1.50

7D

3.8%

1Y

294.7%

Immuron

Market Cap: AU$16.3m

A biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada.

IMC

AU$0.07

7D

-1.4%

1Y

-33.3%

Amplia Therapeutics

Market Cap: AU$27.2m

A clinical-stage drug development company, engages in the development of focal adhesion kinase (FAK) inhibitors for cancer and fibrosis in Australia.

ATX

AU$0.07

7D

-5.4%

1Y

-6.7%

Island Pharmaceuticals

Market Cap: AU$33.7m

A drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America.

ILA

AU$0.17

7D

2.9%

1Y

191.7%

NeuroScientific Biopharmaceuticals

Market Cap: AU$5.5m

Engages in the research and development of novel peptide-based pharmaceutical products.

NSB

AU$0.038

7D

-7.3%

1Y

-20.8%

Tissue Repair

Market Cap: AU$16.0m

A clinical stage biopharmaceutical company, develops advanced wound healing products for chronic wounds and the aftercare of cosmetic procedures in Australia.

TRP

AU$0.27

7D

1.9%

1Y

20.5%

Vitrafy Life Sciences

Market Cap: AU$83.6m

Provides cryopreservation solutions in Australia.

VFY

AU$1.31

7D

-3.7%

1Y

n/a

Tryptamine Therapeutics

Market Cap: AU$46.0m

A clinical-stage pharmaceutical development company, focuses on developing synthetic psilocybin-related molecules in Australia, Canada, Switzerland, and the United States.

TYP

AU$0.036

7D

-5.3%

1Y

n/a

Starpharma Holdings

Market Cap: AU$40.0m

A biopharmaceutical company, engages in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications worldwide.

SPL

AU$0.097

7D

0%

1Y

-25.4%

Chimeric Therapeutics

Market Cap: AU$7.9m

A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.

CHM

AU$0.005

7D

-16.7%

1Y

-83.3%

Noxopharm

Market Cap: AU$25.4m

A biotech company, engages in the discovering and developing treatments for cancer and inflammation, and mRNA vaccines in Australia.

NOX

AU$0.087

7D

19.2%

1Y

42.6%

Cryosite

Market Cap: AU$38.1m

Provides outsourced clinical trials logistic services in Australia.

CTE

AU$0.78

7D

1.3%

1Y

14.7%

Medical Developments International

Market Cap: AU$62.5m

Manufactures and distributes emergency medical solutions in Australia, Europe, the United States, and internationally.

MVP

AU$0.56

7D

-11.2%

1Y

-8.3%

Imugene

Market Cap: AU$253.8m

A clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.

IMU

AU$0.034

7D

-2.9%

1Y

-67.6%

Page 1 of 2